Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients
暂无分享,去创建一个
G. Karanikas | Michael Weber | M. Mayerhoefer | W. Dolak | M. Raderer | I. Rausch | I. Simonitsch-Klupp | K. Kletter | B. Kiesewetter | M. Pones | L. Müllauer | J. Lukas